Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New bosses = new ideas?

This article was originally published in Scrip

Executive Summary

As the pharmaceutical industry braces itself for one of toughest periods in its history it has clearly decided that it is best to do so with fresh ideas from new faces. In the past week we have seen the world's two largest pharma companies announce changes in the top job, as Pfizer replaced Jeff Kindler with Ian Read and Merck promoted Kenneth Frazier to replace Richard Clark as CEO. In both cases, the companies have opted for insiders – in Read's case he has worked for the company for 32 years while Frazier has been at Merck since 1992 – rather than look outside their corporations.

Topics

Related Companies

UsernamePublicRestriction

Register

SC011104

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel